Analysis for Indivior PLC (INDV.L)

Add INDV.L to watchlist(s)

You Should Create a Watchlist In The First Place.

Price Over Time

Profile

Company Name

Indivior PLC

Symbol

INDV.L

Currency

GBp

Exchange

London Stock Exchange

Head Quarter

United States, North Chesterfield

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Website

https://www.indivior.com

ISIN

GB00BN4HT335

CIK

-

CUSIP

G4766E108

UEI

-

LEI

-

Business Description

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet, as well as sells legacy products that include Temgesic, Burpex, and Buprenex.